Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy

Paola Magro, Beatrice Formenti, Valentina Marchese, Maurizio Gulletta, Lina Rachele Tomasoni, Silvio Caligaris, Francesco Castelli, Alberto Matteelli

Source: Eur Respir J, 56 (4) 2002665; 10.1183/13993003.02665-2020
Journal Issue: October
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paola Magro, Beatrice Formenti, Valentina Marchese, Maurizio Gulletta, Lina Rachele Tomasoni, Silvio Caligaris, Francesco Castelli, Alberto Matteelli. Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy. Eur Respir J, 56 (4) 2002665; 10.1183/13993003.02665-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment adherence factors impact on the evolution of tuberculosis cases in Brasov District, Romania
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010


Impact of HIV in tuberculosis incidence in year 2001 in Piedmont Region (Italy)
Source: Eur Respir J 2004; 24: Suppl. 48, 196s
Year: 2004

The epidemiology of tuberculosis and treatment outcomes in the penitentiary system of Lithuania
Source: Eur Respir J 2002; 20: Suppl. 38, 162s
Year: 2002

Prognosis and outcome in patients with extremely drug resistant tuberculosis from the Western Cape province, South Africa
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

Assessment of factors behind treatment delay in pulmonary tuberculosis in southern Estonia
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008


DOTS strategy impact on the tuberculosis endemic evolution in Bucharest (Romania)
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006


Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy
Source: Eur Respir J 2015; 46: 274-277
Year: 2015


Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal
Source: Eur Respir J 2013; 42: 1747-1749
Year: 2013


High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

The impact of SARS-CoV-2 pandemic on tuberculosis – the experience of Iasi County, Romania
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


HIV screening in tuberculosis patients, in the northern region of Portugal
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Programmatic management of drug resistance tuberculosis: Outcome analysis of 200 patients in western part of Rajasthan, India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems
Source: Eur Respir J, 58 (3) 2100839; 10.1183/13993003.00839-2021
Year: 2021



Clinical and epidemiological features of respiratory morbidity in children with latent tuberculosis infection in the Republic of Moldova
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018

Cost-effectiveness of the DOTS strategy of tuberculosis control in Iasi County, Romania
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003

Mortality from tuberculosis, indicator of severity for TB endemia in Romania
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel
Source: Eur Respir J 2008; 32: 413-418
Year: 2008



Risk factors for drug-resistant tuberculosis in the north of Portugal
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011


Tuberculosis (TB) out-patient clinic in a low prevalence country: a 5-year experience of a Northern Italian city
Source: Eur Respir J 2004; 24: Suppl. 48, 415s
Year: 2004

The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region
Source: Eur Respir J, 56 (4) 2003054; 10.1183/13993003.03054-2020
Year: 2020